2.Anorectal motility in children with functional constipation.
Jie-Yu YOU ; Hong-Mei ZHAO ; Wen-Xian OU-YANG
Chinese Journal of Contemporary Pediatrics 2010;12(11):915-917
Adolescent
;
Anal Canal
;
physiopathology
;
Child
;
Constipation
;
physiopathology
;
Female
;
Gastrointestinal Motility
;
physiology
;
Humans
;
Male
;
Rectum
;
physiopathology
3.Current status of surgical management of esophageal cancer in China and the future strategy.
You-Sheng MAO ; Jie HE ; Gui-Yu CHENG
Chinese Journal of Oncology 2010;32(6):401-404
China
;
Esophageal Neoplasms
;
pathology
;
surgery
;
Esophagectomy
;
methods
;
trends
;
Esophagoscopy
;
methods
;
Humans
;
Lymph Node Excision
;
methods
;
Survival Rate
4.Coccidioidomycosis in an infant.
Wen-xian OUYANG ; Jie-yu YOU ; Yi-min ZHU
Chinese Journal of Pediatrics 2008;46(12):934-935
Coccidioides
;
Coccidioidomycosis
;
pathology
;
Humans
;
Infant
;
Male
5.HIGH LEVEL EXPRESSION AND ACTIVITY DETECTION OF SINGLE CHAIN IMMUNOTOXIN 183B_2ScFvPE38 AGAINST OVARIAN CARCINOMA
Fanglei YOU ; Jie FENG ; Yexia CHENG ; Tianyun FU ; Yu YAO ;
Acta Anatomica Sinica 1953;0(01):-
Objective To prepare the immunotoxin protein (183B 2ScFvPE38) which might be useful in immuno guided therapy for ovarian carcinoma and study the activity of the protein. Methods The methods of ELISA and cytotoxicity were used to study the immunotoxin after induced with IPTG and the activity of the immunotoxin. Results The expressed fusion proteins were detected mostly as inclusion bodies at high level, and soluble immunotoxins were also observed. The results showed liable activity of antibody part and toxic part. Conclusion The recombinant fusion protein 183B 2ScFvPE38 keeps the activity of both components and might be of great use in the future to deal with ovarian carcinoma. [
6.Value of electronic colonoscopy in the diagnosis of childhood chronic diarrhea.
Jie-Yu YOU ; Chan-Bin CHEN ; Wen-Xian OU-YANG
Chinese Journal of Contemporary Pediatrics 2007;9(5):493-494
Adolescent
;
Child
;
Child, Preschool
;
Chronic Disease
;
Colonoscopy
;
methods
;
Diarrhea
;
diagnosis
;
pathology
;
Female
;
Humans
;
Infant
;
Infant, Newborn
;
Male
7.Effects of crocetin on VCAM-1 expression in human umbilical vein endothelial cells and monocyte-endothelial cell adhesion.
Shu-guo ZHENG ; Meng-qiu ZHAO ; You-nan REN ; Jie-ren YANG ; Zhi-yu QIAN
Acta Pharmaceutica Sinica 2015;50(1):34-38
Crocetin, a naturally occurring carotenoid, possesses antioxidant and antiatherosclerotic properties, of which the underlying mechanism remains unclear. In the present study, we examined the effects of crocetin (0.1, 1, 10 μmol·L(-1)) on angiotensin II (Ang II, 0.1 μmol·L(-1)) induced expression of vascular cell adhesion molecule-1 (VCAM-1) in human umbilical vein endothelial cells (HUVECs) and monocyte-endothelial cell adhesion. The effects of crocetin on the activation of nuclear factor kappa B (NF-κB) and intracellular reactive oxygen species (ROS) were also observed. The results demonstrated that crocetin notably suppressed Ang II induced NF-κB activation (P<0.01) and VCAM-1 expression (P<0.05, P<0.01) in HUVECs, accompanied by a markedly reduced monocyte-endothelial cell adhesion (P<0.05, P<0.01). In addition, preincubation with crocetin resulted in a significant enhancement of cellular antioxidant capacity (P<0.05, P<0.01), while Ang II induced intracellular ROS decreased markedly (P<0.05, P<0.01). These results indicated that crocetin was capable of suppressing Ang II induced VCAM-1 expression and monocyte-endothelial cell adhesion by suppression of NF-κB activation, which might be derived from the enhancement of antioxidant capacity and subsequent reduction of intracellular ROS.
Angiotensin II
;
metabolism
;
Antioxidants
;
pharmacology
;
Carotenoids
;
pharmacology
;
Cell Adhesion
;
drug effects
;
Human Umbilical Vein Endothelial Cells
;
cytology
;
drug effects
;
metabolism
;
Humans
;
Monocytes
;
cytology
;
NF-kappa B
;
metabolism
;
Reactive Oxygen Species
;
metabolism
;
Vascular Cell Adhesion Molecule-1
;
metabolism
8.Huikangling Tablet Intervened Peripheral Blood Micrometastasis of Differentiated Thyroid Carcinoma.
Qin-jiang LIU ; Yu-jie WANG ; You-xin TIAN ; Jun WANG ; Feng DONG ; Yan DENG
Chinese Journal of Integrated Traditional and Western Medicine 2015;35(11):1302-1306
OBJECTIVETo observe the clinical effect of Huikangling Tablet (HT, extracted from Scabrous Patrinia root) on peripheral blood micrometastasis of differentiated thyroid carcinoma (DTC) patients.
METHODSTotally 87 DTC patients with positive micrometastasis were randomly assigned to the treatment group (45 cases) and the control group (42 cases). DTC endocrine inhibition treatment standards were executed in all patients. They all took levothyroxine sodium (50 microg/tablet, from low dose, 25 microg each time, once per day, 0.5 h before breakfast), and its dosage was gradually added one week later. The dosage was adjusted according to tested results of TSH combined recurrence risk stratification and endocrine suppression induced adverse reactions risk stratification. Patients in the treatment group took HT (0.4 g per tablet, 3 tablets each time, three times per day for a total of 12 weeks) combined TSH suppression therapy, while those in the control group only received TSH suppression therapy. Peripheral micrometastatic cytokeratin 19 (CK19) and polymorphic epithelial mucin1 (MUC1) were detected by FCM at week 4 and 12. Meanwhile, distant metastasis and adverse reactions were observed.
RESULTSAfter 4-week treatment positive micrometastasis was shown in 18 cases (40%) of the treatment group and 29 cases (69%) in the control group with statistical difference (chi2 = 5.68, P < 0.05). After 12-week treatment positive micrometastasis was shown in 7 cases (15.6%) of the treatment group and 17 cases (44.7%) in the control group with statistical difference (chi2 = 8.49, P < 0.01). Pulmonary metastasis occurred in 2 cases and bone metastasis in 1 case of the control group at follow-ups. Cervical lymph node metastasis without accompanied recurrence of thyroid cancer occurred in one case of the treatment group. No obvious liver or renal abnormalities occurred.
CONCLUSIONHT inhibited peripheral blood micrometastasis of DTC patients and its mechanism needed to be further studied.
Antineoplastic Agents ; pharmacology ; therapeutic use ; Drugs, Chinese Herbal ; pharmacology ; therapeutic use ; Humans ; Neoplasm Micrometastasis ; drug therapy ; Neoplasm Recurrence, Local ; Tablets ; Thyroid Neoplasms ; drug therapy
9.HPLC fingerprint of Tibetan medicine Shaji Gao.
Jia-li YOU ; Yu-jie WANG ; Yi ZHANG ; Yang YANG ; Yong-wen SU ; Gang FAN
China Journal of Chinese Materia Medica 2015;40(2):362-366
This study established an HPLC fingerprint of Tibetan medicine Shaji Gao from different habitats and lay a foundation for Shaji Gao varieties identification and preparation process. The chromatographic condition was as follow: Agilent zorbax SB-C18 (4.6 mm x 250 mm, 5 μm) eluted with the mobile phases of acetonitrile and 0.4% phosphoric acid water in gradient mode. The flow rate was 1.0 mL x min(-1), and the detection wavelength was set at 360 nm. The fingerprints of 15 batches Shaji Gao were carried out by similarity comparation, 7 chromatographic peaks were extracted as the common peaks of fingerprint, 3 peaks were identified, which were quercetin, kaempferol and isorhamnetin. The similarity degrees of 14 batches of samples were above 0.9 and 1 batch of samples was below 0.9. This is the first established fingerprint of Shaji Gao by using HPLC. This method has good precision, stability and repeatability that it could provide basis for quality control and evaluation of Shaji Gao.
Chromatography, High Pressure Liquid
;
methods
;
Medicine, Tibetan Traditional
;
Quality Control